Chukwuma Chukwu

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Heart failure and acute renal dysfunction in the cardiorenal syndrome

Rajinder S Chahal, Chukwuma Chukwu, Paul R. Kalra et al. · Clinical Medicine · 2020 · 36 citations · Full text

Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre

Chukwuma Chukwu, Kassir Mahmood, Safa Elmakki et al. · PLoS ONE · 2022 · 26 citations · Full text

In Vivo and in Silico Assessment of Ameliorative Effects of Xylopia aethiopica on Testosterone Propionate-Induced Benign Prostatic Hyperplasia

Daniel Ejim Uti, Chris C. Ejeogo, O.U. Orji et al. · Pharmaceutical Fronts · 2023 · 17 citations · Full text

Spermatogenesis, Gynecology, Reproductive Biology +20